8.04
-0.37%
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Integrum
Its shares trade on Nasdaq Stockholm under the ticker INTEG B.ST. It has been listed since 15 May 2017. In the fiscal year to 30 April 2025, it reported revenue of SEK 91.1m and a net loss of SEK 30.8m. At that date it held total assets of SEK 203.1m and shareholders' equity of SEK 177.7m.
Integrum AB engages in the manufacturing of medical devices. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2017-05-15. The company provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The firm provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 15 May 2017
- Employees
- 31
- Website
- integrum.se ↗
Leadership
Pay as last reported
- Mr. Bengt SjoholmChairman of the Board, since 2019
- Mr. Martin HillstenChief Executive Officer
- Ms. Louise WaehlinChief Financial Officer
- Ms. Anna-Tove BranemarkChief Executive Officer of Integrum Inc. and Clinical Specialist
- Mr. Thomas DuganPresident - US
- Mr. Niklas HofverbergQA/RA Manager
- Dr. Max Ortiz CatalanResearch Director
- Mr. Artur AiraDirector
- Mr. Andrew ChristensenDirector
- Mr. Scott FloraDirector, since 2023
- Mr. Lennart RambergDirectorSEK 33,000
- Mr. Magnus ReneDirectorSEK 33,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Integrum AB's OPRA Implant System enables direct skeletal connection for artificial limbs.
- Neural prosthetics connect bionic prostheses directly to bone, nerves, and muscles.
- Machine learning aids phantom limb pain treatment using virtual reality.
Weaknesses
- Integrum AB has only 31 employees in the Health Care sector.
- The company's IPO was on 15 May 2017, limiting recent growth.
- Integrum AB is headquartered in Moelndal, Vastra Gotalands, a small city.
Opportunities
- Integrum AB can expand its neural prosthetics technology in the Health Care industry.
- The company can grow its OPRA Implant System market in Sweden.
- Integrum AB can leverage machine learning for new prosthetic components.
Threats
- Integrum AB faces competition from other Health Care companies in Sweden.
- The Health Care sector has strict regulatory requirements in Sweden.
- Integrum AB's small employee count may limit scalability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.